跳至主要内容
临床试验/NCT00477230
NCT00477230终止3 期

Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System for the Treatment of Symptomatic Atrial Fibrillation (AF)

CardioFocus18 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2007年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
终止
发起方
CardioFocus
入组人数
64
试验地点
18
主要终点
Freedom for Symptomatic Episode of Atrial Fibrillation at One Year

研究概览

简要总结

The purpose of the study is to compare two types of treatment for atrial fibrillation (AF) that are designed to treat the symptoms of atrial fibrillation. The treatments being compared are:

  • A single catheter ablation procedure with the investigational EAS, a visually-guided, light-energy catheter
  • Standard drug therapy (antiarrhythmic drugs)

To learn more about the CardioFocus ENABLE investigational clinical study, please contact the study site closest to you.

Eligibility Criteria

Persons with paroxysmal atrial fibrillation may be eligible for this study. Other study eligibility criteria include:

  • 18 to 80 years of age
  • Frequent episodes of AF
  • Failed at least 1 drug treatment for AF (beta-blockers or standard AADs)
  • Other criteria

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 to 80 years old
  • Paroxysmal atrial fibrillation (AF)
  • Frequent episodes of AF
  • Failed at least 1 drug treatment

排除标准

  • 未提供

研究组 & 干预措施

1

Experimental

Single ablation procedure with Endoscopic Ablation System

干预措施: Endoscopic Ablation System (Device)

2

Active Comparator

Medication

干预措施: Standard Anti-arrhythmic Drug (AAD) Therapy (Drug)

结局指标

主要结局

Freedom for Symptomatic Episode of Atrial Fibrillation at One Year

时间窗: One Year

次要结局

未报告次要终点

研究者

发起方
CardioFocus
申办方类型
Industry
责任方
Sponsor

研究点 (18)

Loading locations...

相似试验